Oxidative stress, t cell dna methylation, and lupus

Arthritis and Rheumatology

Volumn 66, Issue 6, 2014, Pages 1574-1582

  Li, Yepeng ^a   Gorelik, Gabriela ^a   Strickland, Faith M ^a   Richardson, Bruce C ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD70 ANTIGEN; DNA METHYLTRANSFERASE 1; HYDRALAZINE; HYDROGEN PEROXIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C DELTA; SUPEROXIDE DISMUTASE;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DNA METHYLATION; ENZYME PHOSPHORYLATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUPUS VULGARIS; MALE; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; FEMALE; HUMANS; HYDROGEN PEROXIDE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; OXIDATIVE STRESS; PEROXYNITROUS ACID; PROTEIN KINASE C-DELTA;

EID: 84901641141     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38427     Document Type: Article

References (43)

1. Rullo OJ, Tsao BP,. Recent insights into the genetic basis of systemic lupus erythematosus. Ann Rheum Dis 2013; 72 Suppl 2: ii56-61.
2. Bogdanos DP, Smyk DS, Rigopoulou EI, Mytilinaiou MG, Heneghan MA, Selmi C, et al. Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun 2012; 38: J156-69.
3. Richardson B,. Primer: epigenetics of autoimmunity. Nat Clin Pract Rheumatol 2007; 3: 521-7.
4. Cooper GS, Gilbert KM, Greidinger EL, James JA, Pfau JC, Reinlib L, et al. Recent advances and opportunities in research on lupus: environmental influences and mechanisms of disease. Environ Health Perspect 2008; 116: 695-702.
5. Zandman-Goddard G, Solomon M, Rosman Z, Peeva E, Shoenfeld Y,. Environment and lupus-related diseases. Lupus 2012; 21: 241-50.
6. Rogers MA, Levine DA, Blumberg N, Fisher GG, Kabeto M, Langa KM,. Antigenic challenge in the etiology of autoimmune disease in women. J Autoimmun 2012; 38: J97-102.
7. Richardson B, Somers E,. Environmental exposures, epigenetic changes and the risk of lupus. Lupus. In press.
8. Nagy G, Koncz A, Fernandez D, Perl A,. Nitric oxide, mitochondrial hyperpolarization, and T cell activation. Free Radic Biol Med 2007; 42: 1625-31.
9. Oates JC, Shaftman SR, Self SE, Gilkeson GS,. Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis. Arthritis Rheum 2008; 58: 263-72.
10. Oates JC, Gilkeson GS,. The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus. Clin Immunol 2006; 121: 243-50.
11. Morgan PE, Sturgess AD, Davies MJ,. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus. Arthritis Rheum 2005; 52: 2069-79.
12. Cornacchia E, Golbus J, Maybaum J, Strahler J, Hanash S, Richardson B,. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J Immunol 1988; 140: 2197-200.
13. Deng C, Lu Q, Zhang Z, Rao T, Attwood J, Yung R, et al. Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. Arthritis Rheum 2003; 48: 746-56.
14. Strickland FM, Hewagama A, Lu Q, Wu A, Hinderer R, Webb R, et al. Environmental exposure, estrogen and two X chromosomes are required for disease development in an epigenetic model of lupus. J Autoimmun 2012; 38: J135-43.
15. Sawalha AH, Jeffries M, Webb R, Lu Q, Gorelik G, Ray D, et al. Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients. Genes Immun 2008; 9: 368-78.
16. Gorelik G, Fang JY, Wu A, Sawalha AH, Richardson B,. Impaired T cell protein kinase Cδ activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus. J Immunol 2007; 179: 5553-63.
17. Gorelik GJ, Yarlagadda S, Patel D, Richardson BC,. Protein kinase Cδ oxidation contributes to ERK inactivation in lupus T cells [published erratum appears in Arthritis Rheum 2014;66:769]. Arthritis Rheum 2012; 64: 2964-74.
18. Lu Q, Richardson B,. Methods for analyzing the role of DNA methylation and chromatin structure in regulating T lymphocyte gene expression. Biol Proced Online 2004; 6: 189-203.
19. Basu D, Liu Y, Wu A, Yarlagadda S, Gorelik GJ, Kaplan MJ, et al. Stimulatory and inhibitory killer Ig-like receptor molecules are expressed and functional on lupus T cells. J Immunol 2009; 183: 3481-7.
20. Liu Y, Kuick R, Hanash S, Richardson B,. DNA methylation inhibition increases T cell KIR expression through effects on both promoter methylation and transcription factors. Clin Immunol 2009; 130: 213-24.
21. - T cells. Clin Immunol 2009; 132: 257-65.
22. Lu Q, Wu A, Richardson BC,. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs. J Immunol 2005; 174: 6212-9.
23. Uhrberg M, Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B, et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997; 7: 753-63.
24. Herzog E, Galvez J, Roks A, Stolk L, Verbiest M, Eilers P, et al. Tissue-specific DNA methylation profiles in newborns. Clin Epigenetics 2013; 5: 8.
25. Patel DR, Richardson BC,. Dissecting complex epigenetic alterations in human lupus. Arthritis Res Ther 2013; 15: 201.
26. Middleton D, Williams F, Halfpenny IA,. KIR genes. Transpl Immunol 2005; 14: 135-42.
27. Gillissen A, Nowak D,. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. Respir Med 1998; 92: 609-23.
28. Novaes R, Freire-de-Lima CG, de Albuquerque RC, Affonso-Mitidieri OR, Espindola O, Lima MA, et al. Modulation of glutathione intracellular levels alters the spontaneous proliferation of lymphocyte from HTLV-1 infected patients. Immunobiology 2013; 218: 1166-74.
29. Lai ZW, Hanczko R, Bonilla E, Caza TN, Clair B, Bartos A, et al. N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2012; 64: 2937-46.
30. - T cells in immune disorders. Trends Mol Med 2012; 18: 446-53.
31. - T cells through epigenetic mechanisms. J Leukoc Biol 2010; 87: 137-45.
32. Wu-Zhang AX, Newton AC,. Protein kinase C pharmacology: refining the toolbox. Biochem J 2013; 452: 195-209.
33. Gorelik G, Barreiro Arcos ML, Klecha AJ, Cremaschi GA,. Differential expression of protein kinase C isoenzymes related to high nitric oxide synthase activity in a T lymphoma cell line. Biochim Biophys Acta 2002; 1588: 179-88.
34. Tirosh O, Aronis A, Melendez JA,. Mitochondrial state 3 to 4 respiration transition during Fas-mediated apoptosis controls cellular redox balance and rate of cell death. Biochem Pharmacol 2003; 66: 1331-4.
35. Passam FH, Giannakopoulos B, Mirarabshahi P, Krilis SA,. Molecular pathophysiology of the antiphospholipid syndrome: the role of oxidative post-translational modification of β2 glycoprotein I. J Thromb Haemost 2011; 9 Suppl 1: 275-82.
36. Lu Q, Kaplan M, Ray D, Ray D, Zacharek S, Gutsch D, et al. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum 2002; 46: 1282-91.
37. Lu Q, Wu A, Ray D, Deng C, Attwood J, Hanash S, et al. DNA methylation and chromatin structure regulate T cell perforin gene expression. J Immunol 2003; 170: 5124-32.
38. Lu Q, Wu A, Tesmer L, Ray D, Yousif N, Richardson B,. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J Immunol 2007; 179: 6352-8.
39. Rehman T, Fought J, Solomon R,. N-acetylcysteine effect on serum creatinine and cystatin C levels in CKD patients. Clin J Am Soc Nephrol 2008; 3: 1610-4.
40. Izzedine H, Guerin V, Launay-Vacher V, Bernard M, Deray G,. Effect of N-acetylcysteine on serum creatinine level. Nephrol Dial Transplant 2001; 16: 1514-15.
41. Fernandez D, Perl A,. mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus? Discov Med 2010; 9: 173-8.
42. Moulton VR, Tsokos GC,. Abnormalities of T cell signaling in systemic lupus erythematosus. Arthritis Res Ther 2011; 13: 207.
43. Patel DR, Richardson BC,. Epigenetic mechanisms in lupus. Curr Opin Rheumatol 2010; 22: 478-82.